Latest on Ultrasound Renal Denervation

Published: 22 June 2022

  • Views:

    Views Icon 7839
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 7 | Session 1 of 2
    ACC 2022 Symposium
    Michael Weber, Felix Mahfoud, Ajay J Kirtane, Michael Bloch
    Up Next
  • episode_image
    59m 32s
    Part 7 | Session 2 TCT 2021 Symposium
    Chandan Devireddy, Ajay J Kirtane, Felix Mahfoud, Naomi Fisher
Average (ratings)
No ratings
Your rating

Overview

Ultrasound Renal Denervation (uRDN) is an innovative therapy option for the treatment of uncontrolled hypertension. uRDN therapy is delivered in a minimally invasive procedure that may lower high blood pressure by treating overactive renal nerves with ultrasound energy.

 

This page provides an overview of uRDN technology and the latest evidence from its associated RADIANCE clinical program.

 

The PARADISETM System is Limited to Investigational Use Only in the United States. Approved for distribution in CE mark countries only.
This educational content is supported by:

What you will learn:

  • How uRDN works and its potential benefits for patients suffering from uncontrolled hypertension
  • The clinical evidence supporting uRDN and its implications for the field of hypertension
  • The process for building a uRDN centre and therapy network

This page is designed for:

  • Interventional cardiologists
  • General cardiologists
  • Hypertension specialists
  • Nephrologists
  • Interventional radiologists

More from this programme

Part 4

RADIANCE II Pivotal Trial for Paradise Ultrasound Renal Denervation System in Patients With Hypertension

Part 6

Patient Perspective & Provider Referral Development

Understand patient preference and referral development

Part 7

Discussion With Experts

Faculty Biographies

Michael Weber

Michael Weber

Professor of Medicine

Dr Weber is Professor of Medicine and Associate Dean for Research at the SUNY Downstate College of Medicine in Brooklyn, New York. He received his medical degree from Sydney University in Australia. His career has been focused primarily on hypertension and preventive cardiology. 

Dr Weber was one of the founders of The American Society of Hypertension and has served as its President. He is a Fellow of the American College of Physicians, the American College of Cardiology, and the American Heart Association. 

Dr Weber's main research interests include the role of the renin-angiotensin system in the genesis of hypertension and as a major factor in cardiovascular prognosis. 

View full profile
Felix Mahfoud

Felix Mahfoud

Professor of Cardiology and Chairman of the Department of Cardiology

Prof Felix Mahfoud is a Professor of Cardiology at the University of Basel and the Chairman of the Department of Cardiology at University Hospital Basel, Switzerland. He also holds a position as Visiting Professor at Harvard-MIT, Biomedical Engineering in Boston, MA. 

Prof Mahfoud is board-certified in internal medicine, cardiology, intensive care medicine, emergency medicine and hypertension. He is Deputy Editor of the European Journal of Heart Failure and is a Councillor on the Board of the European Society of Cardiology (ESC) for 2024-2026. Additionally, he chairs both the ESC Communication Committee and the Scientific Documents Committee of the EAPCI for the 2024-2026 term. 

He has published more than 500 publications in peer-reviewed journals and contributed as a wiring committee member to the 2019 ESC Guidelines for the…

View full profile
Ajay J Kirtane

Ajay J Kirtane

Professor of Clinical Medicine

Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.

 

In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…

View full profile
Michael Bloch

Michael Bloch

Associate Professor

Dr Bloch is an Associate Professor, Department of Internal Medicine at University of Nevada School of Medicine and also Medical Director of Vascular Medicine and Anticoagulation Services at the Renown Medical Center Institute for Heart and Vascular Health.

His undergraduate degree is from Princeton University, and he earned his medical degree from Georgetown University Medical School in Washington, DC.

Dr Bloch is also Fellow in the American College of Physicians, the American Society of Hypertension, the National Lipid Association, and the Society of Vascular Medicine. 

View full profile